Primary Central Nervous System Non-Hodgkin Lymphoma

Primary Central Nervous System Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 1
Ph III recruiting: 1
Growth YoY: —
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04609046	Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma	active not recruiting	Phase 1	47	National Cancer Institute (NCI)NIH	1	Sep 4, 2026	clinicaltrials
NCT05211336	Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System	active not recruiting	Phase 1	14	National Cancer Institute (NCI)NIH	1	Jan 8, 2026